A Prospective Study Evaluating the Safety and Effectiveness of EVARREST® Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic and Thoracic (Non-cardiac) Surgery in Pediatric Patients
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Fibrin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.
- 17 Oct 2017 Planned initiation date changed from 31 Aug 2017 to 31 Oct 2017.
- 23 Aug 2017 New trial record